From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Are Proton-Pump Inhibitors Beneficial for Patients with Poorly Controlled Asthma?

For patients with minimal heartburn, probably not

Because acid reflux can cause bronchoconstriction, NIH asthma guidelines state the following: "For patients who have poorly controlled asthma . . . investigation for GERD [gastroesophageal reflux disease] may be warranted even in the absence of suggestive symptoms."

To determine whether treatment of occult acid reflux is worthwhile for asthma patients, 412 adults with inadequately controlled asthma were randomized to receive the proton-pump inhibitor (PPI) esomeprazole (Nexium; 40 mg twice daily) or placebo. Reasoning that patients who have highly symptomatic GERD — with or without asthma — would receive acid-suppressive therapy anyway, researchers excluded patients who required medication for heartburn more than once weekly. On ambulatory pH monitoring, 40% of patients exhibited esophageal reflux.

During 6 months of treatment, clinical outcomes and pulmonary function outcomes were not significantly better in the esomeprazole group than in the placebo group. The subgroup of patients with acid reflux (documented by pH monitoring) also did not benefit from esomeprazole.

Comment: This trial shows that treatment with PPIs is not warranted for asthma patients with mild or no heartburn. The findings undermine the NIH recommendation quoted above; we have no reason to investigate asthma patients for silent reflux if PPI therapy is ineffective. In fact, in another recent study, PPI therapy did not convincingly improve asthma symptoms even among patients with highly symptomatic GERD (JW Gen Med Jun 6 2006).

Allan S. Brett, MD

Published in Journal Watch General Medicine April 16, 2009

Citation(s):

The American Lung Association Asthma Clinical Research Centers. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009 Apr 9; 360:1487.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.